Literature DB >> 24229639

Test-retest reliability and sensitivity to change of the dimensional anxiety scales for DSM-5.

Susanne Knappe1, Jens Klotsche1, Franziska Heyde1, Sarah Hiob1, Jens Siegert1, Jürgen Hoyer1, Anja Strobel2, Richard T LeBeau3, Michelle G Craske3, Hans-Ulrich Wittchen1, Katja Beesdo-Baum1.   

Abstract

OBJECTIVE: This article reports on the test-retest reliability and sensitivity to change of a set of brief dimensional self-rating questionnaires for social anxiety disorder (SAD-D), specific phobia (SP-D), agoraphobia (AG-D), panic disorder (PD-D), and generalized anxiety disorder (GAD-D), as well as a general cross-cutting anxiety scale (Cross-D), which were developed to supplement categorical diagnoses in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5).
METHODS: The German versions of the dimensional anxiety scales were administered to 218 students followed up approximately 2 weeks later (Study 1) and 55 outpatients (23 with anxiety diagnoses) followed-up 1 year later (Study 2). Probable diagnostic status in students was determined by the DIA-X/M-CIDI stem screening-questionnaire (SSQ). In the clinical sample, Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) diagnoses were assessed at Time 1 using the DIA-X/M-CIDI. At Time 2, the patient-version of the Clinical Global Impression-Improvement scale (CGI-I) was applied to assess change.
RESULTS: Good psychometric properties, including high test-retest reliability, were found for the dimensional scales except for SP-D. In outpatients, improvement at Time 2 was associated with significant decrease in PD-D, GAD-D, and Cross-D scores. Discussion Major advantages of the scales include that they are brief, concise, and based on a consistent template to measure the cognitive, physiological, and behavioral symptoms of fear and anxiety. Further replication in larger samples is needed. Given its modest psychometric properties, SP-D needs refinement.
CONCLUSION: Increasing evidence from diverse samples suggests clinical utility of the dimensional anxiety scales.

Entities:  

Mesh:

Year:  2013        PMID: 24229639     DOI: 10.1017/S1092852913000710

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  8 in total

1.  Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample.

Authors:  Diogo A DeSousa; André L Moreno; Flávia L Osório; José Alexandre S Crippa; Richard LeBeau; Gisele G Manfro; Giovanni A Salum; Silvia H Koller
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-16       Impact factor: 4.035

Review 2.  A Review of Scales to Measure Social Anxiety Disorder in Clinical and Epidemiological Studies.

Authors:  Quincy J J Wong; Bree Gregory; Lauren F McLellan
Journal:  Curr Psychiatry Rep       Date:  2016-04       Impact factor: 5.285

Review 3.  [Anxiety disorders in DSM-5: an overview on changes in structure and content].

Authors:  H-U Wittchen; I Heinig; K Beesdo-Baum
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

4.  Process-symptom-bridges in psychotherapy: An idiographic network approach.

Authors:  Tim Kaiser; Anton-Rupert Laireiter
Journal:  J Pers Oriented Res       Date:  2018-12-26

5.  Psychometric validation of a brief self-report measure of misophonia symptoms and functional impairment: The duke-vanderbilt misophonia screening questionnaire.

Authors:  Zachary J Williams; Carissa J Cascio; Tiffany G Woynaroski
Journal:  Front Psychol       Date:  2022-07-22

6.  The DSM-5 Dimensional Anxiety Scales in a Dutch non-clinical sample: psychometric properties including the adult separation anxiety disorder scale.

Authors:  Eline L Möller; Susan M Bögels
Journal:  Int J Methods Psychiatr Res       Date:  2016-07-05       Impact factor: 4.035

7.  Amygdala functional connectivity as a longitudinal biomarker of symptom changes in generalized anxiety.

Authors:  Elena Makovac; David R Watson; Frances Meeten; Sarah N Garfinkel; Mara Cercignani; Hugo D Critchley; Cristina Ottaviani
Journal:  Soc Cogn Affect Neurosci       Date:  2016-06-30       Impact factor: 3.436

8.  [Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies].

Authors:  Pedro Amariles; Daniel Pino-Marín; Daniel Sabater-Hernández; Emilio García-Jiménez; Inés Roig-Sánchez; María José Faus
Journal:  Aten Primaria       Date:  2016-04-30       Impact factor: 1.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.